MUC17 and cancer: As has been shown in whole exome analyses to identify novel cancer genes, statistical methods that select for sequences mutated at higher frequency than expected are not sufficient to detect driver mutations and often result in the detection of false positives, such as genes like TTN or MUC17, that are neither expressed in the tumor nor in its associated normal tissue14–16.